These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 20527081)

  • 1. Prophylactic platelet transfusions.
    Focosi D
    N Engl J Med; 2010 Jun; 362(22):2140-1; author reply 2141-2. PubMed ID: 20527081
    [No Abstract]   [Full Text] [Related]  

  • 2. Prophylactic platelet transfusions.
    Estcourt LJ; Stanworth SJ; Murphy MF
    Curr Opin Hematol; 2010 Sep; 17(5):411-7. PubMed ID: 20601869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic platelet transfusions.
    Valeri CR; Ragno GM
    N Engl J Med; 2010 Jun; 362(22):2141; author reply 2141-2. PubMed ID: 20527061
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy of prophylactic transfusions using single donor apheresis platelets versus pooled platelet concentrates in AML/MDS patients receiving allogeneic hematopoietic stem cell transplantation.
    Gurkan E; Patah PA; Saliba RM; Ramos CA; Anderson BS; Champlin R; de Lima M; Lichtiger B
    Bone Marrow Transplant; 2007 Sep; 40(5):461-4. PubMed ID: 17589530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profound thrombocytopenia and survival of hematopoietic stem cell transplant patients without clinically significant bleeding, using prophylactic platelet transfusion triggers of 10 x 10(9) or 20 x 10(9) per L.
    Nevo S; Fuller AK; Zahurak ML; Hartley E; Borinsky ME; Vogelsang GB
    Transfusion; 2007 Sep; 47(9):1700-9. PubMed ID: 17725737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. They took a mulligan and mostly got it right … the issue of prophylactic platelet transfusion for patients receiving autologous stem cell transplantation.
    Schiffer CA
    Transfusion; 2014 Oct; 54(10):2372-4. PubMed ID: 25302734
    [No Abstract]   [Full Text] [Related]  

  • 7. Platelet Transfusions in Patients with Hypoproliferative Thrombocytopenia: Conclusions from Clinical Trials and Current Controversies.
    Crighton GL; Estcourt LJ; Wood EM; Stanworth SJ
    Hematol Oncol Clin North Am; 2016 Jun; 30(3):541-60. PubMed ID: 27112995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute bleeding complications in patients after hematopoietic stem cell transplantation with prophylactic platelet transfusion triggers of 10 x 10(9) and 20 x 10(9) per L.
    Nevo S; Fuller AK; Hartley E; Borinsky ME; Vogelsang GB
    Transfusion; 2007 May; 47(5):801-12. PubMed ID: 17465944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different Platelet Count Thresholds to Guide Use of Prophylactic Platelet Transfusions for Patients With Hematological Disorders After Myelosuppressive Chemotherapy or Stem Cell Transplantation.
    Estcourt LJ; Stanworth SJ; Murphy MF
    JAMA Oncol; 2016 Aug; 2(8):1091-2. PubMed ID: 27415031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interventions to reduce platelet prophylactic transfusions in patients with hypoproliferative thrombocytopenia: providing patients with the full benefit.
    Vamvakas EC; Hitzler WE
    Clin Lab; 2013; 59(5-6):459-64. PubMed ID: 23865342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized study of buffy coat platelets in platelet additive solution stored 1-5 versus 6-7 days prior to prophylactic transfusion of allogeneic haematopoietic progenitor cell transplant recipients.
    Diedrich B; Ringdén O; Watz E; Shanwell A
    Vox Sang; 2009 Oct; 97(3):254-9. PubMed ID: 19508669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A therapeutic platelet transfusion strategy is safe and feasible in patients after autologous peripheral blood stem cell transplantation.
    Wandt H; Schaefer-Eckart K; Frank M; Birkmann J; Wilhelm M
    Bone Marrow Transplant; 2006 Feb; 37(4):387-92. PubMed ID: 16400342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylactic platelet transfusions.
    Cid J; Escolar G; Lozano M
    N Engl J Med; 2010 Jun; 362(22):2140; author reply 2141-2. PubMed ID: 20519690
    [No Abstract]   [Full Text] [Related]  

  • 14. Platelet transfusion prophylaxis for patients with haematological malignancies: where to now?
    Stanworth SJ; Hyde C; Brunskill S; Murphy MF
    Br J Haematol; 2005 Dec; 131(5):588-95. PubMed ID: 16351634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet transfusion goals in oncology patients.
    Fasano RM; Josephson CD
    Hematology Am Soc Hematol Educ Program; 2015; 2015():462-70. PubMed ID: 26637759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimizing platelet transfusion therapy.
    Heal JM; Blumberg N
    Blood Rev; 2004 Sep; 18(3):149-65. PubMed ID: 15183900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoplastic thrombocytopenia and platelet transfusion: therapeutic goals.
    Karakatsanis SJ; Papadatos SS; Syrigos KN
    Hosp Pract (1995); 2019 Feb; 47(1):16-23. PubMed ID: 30409035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic platelet transfusion threshold during therapy for adult acute myeloid leukemia: 10,000/microL versus 20,000/microL.
    Navarro JT; Hernández JA; Ribera JM; Sancho JM; Oriol A; Pujol M; Millá F; Feliu E
    Haematologica; 1998 Nov; 83(11):998-1000. PubMed ID: 9864920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased platelet transfusion requirement is associated with multiple organ dysfunctions in patients undergoing hematopoietic stem cell transplantation.
    Gordon B; Tarantolo S; Ruby E; Stephens L; Lynch J; Kessinger A; Haire W
    Bone Marrow Transplant; 1998 Nov; 22(10):999-1003. PubMed ID: 9849698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombocytopenia and platelet transfusions in patients with cancer.
    Valent J; Schiffer CA
    Cancer Treat Res; 2011; 157():251-65. PubMed ID: 21052961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.